Purpose: Nonalcoholic fatty liver disease (NAFLD) is considered the most common form of silent liver disease in the United States and obesity is associated with increased risk of NAFLD. Obstructive sleep apnea (OSA) which is common in obese individuals is associated with a greater incidence of NAFLD, which in turn, increases the risk for hepatocellular carcinoma (HCC). It is unclear how obesity, OSA and NAFLD interrelate nor how they collectively contribute to an increased risk for developing HCC. Patients and methods: Male BALB/c mice were exposed to diethylnitrosamine and phenobarbital followed by 48 weeks of either standard chow diet (chow), chow with hypoxia, high-fat diet, or a combination of hypoxia and high-fat diet. We noninvasively...
Rationale: Obstructive sleep apnea syndrome (OSAS) and nonalcoholic fatty liver disease (NAFLD) are ...
Copyright © 2015 Elena Paschetta et al.This is an open access article distributed under the Creative...
Background: The transition from steatosis to non-alcoholic steatohepatitis (NASH) is a key issue in ...
Primary liver cancer is the seventh most common cancer worldwide and the second highest cause of can...
NAFLD (non-alcoholic fatty liver disease) represents a spectrum of fatty liver diseases associated w...
Background: Both obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) are pre...
BACKGROUND/AIMS: Chronic intermittent hypoxia (CIH) is associated with recurrent episodes of oxygen ...
Introduction: In Norway, 58 % of men and 47 % of women are classified as overweight or obese, which ...
Megan E. Rosa1, Matthew P. Harris2, David E. Lee1, Jacob L. Brown1, Kaylee E. Poole2, Andrew Seija2,...
BACKGROUND: Obstructive sleep apnea syndrome (OSAS) is associated to intermittent hypoxia (IH) and i...
Obesity is a global epidemic and overwhelming evidence indicates that it is a risk factor for numero...
The metabolic disorders that predispose patients to NASH (non-alcoholic steatohepatitis) include ins...
Nonalcoholic fatty liver disease (NAFLD) encompasses a clinicopathologic spectrum of diseases rangin...
Background: Obstructive sleep apnea (OSA) causes chronic intermittent hypoxia (CIH) during sleep. OS...
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) ranks first among liver diseases in Western co...
Rationale: Obstructive sleep apnea syndrome (OSAS) and nonalcoholic fatty liver disease (NAFLD) are ...
Copyright © 2015 Elena Paschetta et al.This is an open access article distributed under the Creative...
Background: The transition from steatosis to non-alcoholic steatohepatitis (NASH) is a key issue in ...
Primary liver cancer is the seventh most common cancer worldwide and the second highest cause of can...
NAFLD (non-alcoholic fatty liver disease) represents a spectrum of fatty liver diseases associated w...
Background: Both obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) are pre...
BACKGROUND/AIMS: Chronic intermittent hypoxia (CIH) is associated with recurrent episodes of oxygen ...
Introduction: In Norway, 58 % of men and 47 % of women are classified as overweight or obese, which ...
Megan E. Rosa1, Matthew P. Harris2, David E. Lee1, Jacob L. Brown1, Kaylee E. Poole2, Andrew Seija2,...
BACKGROUND: Obstructive sleep apnea syndrome (OSAS) is associated to intermittent hypoxia (IH) and i...
Obesity is a global epidemic and overwhelming evidence indicates that it is a risk factor for numero...
The metabolic disorders that predispose patients to NASH (non-alcoholic steatohepatitis) include ins...
Nonalcoholic fatty liver disease (NAFLD) encompasses a clinicopathologic spectrum of diseases rangin...
Background: Obstructive sleep apnea (OSA) causes chronic intermittent hypoxia (CIH) during sleep. OS...
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) ranks first among liver diseases in Western co...
Rationale: Obstructive sleep apnea syndrome (OSAS) and nonalcoholic fatty liver disease (NAFLD) are ...
Copyright © 2015 Elena Paschetta et al.This is an open access article distributed under the Creative...
Background: The transition from steatosis to non-alcoholic steatohepatitis (NASH) is a key issue in ...